TFAM and Hyperglycemia: Studies have shown that chronic hyperglycaemia reduces the expression levels of PGC-1α and TFAM [48], while activation of PGC1-α and increased expression of TFAM protect against HG-mediated podocyte injury by promoting mitochondrial biogenesis [49].